Assessment of cancer recurrence in residual tumors after fractionated radiotherapy: A comparison of fluorodeoxyglucose, L-methionine and thymidine

Journal of Nuclear Medicine

Volumn 38, Issue 2, 1997, Pages 280-287

  Reinhardt, Michael J ^a,b   Kubota, Kazuo ^a   Yamada, Susumu ^a   Iwata, Ren ^a   Yaegashi, Hiroshi ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

carbon 11 methionine; carbon 11 thymidine; fluorine 18 FDG; fractionated radiotherapy

Indexed keywords

CARBON 11; CARBON 14; FLUORINE 18; FLUORODEOXYGLUCOSE; METHIONINE; THYMIDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CONTROLLED STUDY; DOSE RESPONSE; DRUG UPTAKE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION DOSE; TISSUE DISTRIBUTION;

ANIMALS; AUTORADIOGRAPHY; CARBON RADIOISOTOPES; DEOXYGLUCOSE; DOSE-RESPONSE RELATIONSHIP, RADIATION; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; MALE; METHIONINE; NEOPLASM, RESIDUAL; NEOPLASMS, EXPERIMENTAL; RADIOPHARMACEUTICALS; RATS; THYMIDINE; TOMOGRAPHY, EMISSION-COMPUTED; TRITIUM;

EID: 0031039312     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Fujiwara T, Matsuzawa T, Kubota K, et al. Relationship between histologic type of primary lung cancer and carbon-11-L-methionine uptake with positron emission tomography. J Nucl Med 1989;30:33-37.
2. Greven KM, Williams DW, Keyes JW, et al. Positron emission tomography of patients with head and neck carcinoma before and after high-dose irradiation. Cancer 1994;74:1355-1359.
3. Haberkorn U, Strauss LG, Dimitrakopoulu A, et al. PET studies of fluoro-deoxyglucose metabolism in patients with recurrent colorectal tumors receiving radiotherapy. J Nucl Med 1991;32:1485-1490.
4. Ichiya Y, Kubawara Y, Otsuka M, et al. Assessment of response to cancer therapy using fluorine-18-fluorodeoxyglucose and positron emission tomography. J Nucl Med 1991;32:1655-1660.
5. Inoue T, Kim EE, Komaki R, et al. Detecting recurrent or residual lung cancer with FDG-PET. J Nucl Med 1995;36:788-793.
6. Leskinen-Kallio S, Nagren K., Lehikoinen P, Ruotsalainen U, Teraes M, Joensuu H. Carbon-11-methionine and PET is an effective method to image head and neck cancer. J Nucl Med 1992;33:691-695.
7. Minn H, Paul R, Ahonen A. Evaluation of treatment response to radiotherapy in head and neck cancer with fluorine-18-fluorodeoxyglucose. J Nucl Med 1988;29:1521-1525.
8. Engenhart R, Kimmig BN, Strauss LG, et al. Therapy monitoring of presacral recurrences after high-dose irradiation: value of PET, CT, CEA and pain score. Strahlenther Onkol 1992;168:203-212.
9. Kim EE, Garcia JR, Wong FCL, et al. Differentiation of thoracic tumors from post-treatment changes using PET with F-18 FDG and C-11 methionine [Abstract]. J Nucl Med 1994;35:76P.
10. Kubota R, Kubota K, Yamada S, et al. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 1992;33:1972-1980.
11. Kubota R, Kubota K, Yamada S, et al. Methionine uptake by tumor tissue: a microautoradiographic comparison with FDG. J Nucl Med 1995;36:484-492.
12. Gragoudas ES, Egan KM, Saornil MA, Walsh SM, Albert DM, Seddon JM. The time course after irradiation changes in proton beam treated uveal melanomas. Ophthalmology 1993;100:1555-1559.
13. Kobayashi M. The irradiation effects on the cytoskeletons of C3H/He mouse mammary tumor cells and vascular basement membrane in relation to vascular invasion: a model of intraoperative radiotherapy. Tohoku J Exp Med 1988;154:71-89.
14. Van Limbergen E, Rijnders A, van der Schueren E, Lerut T, Christiaens R. Cosmetic evaluation of breast conserving treatment for mammary cancer. A quantitative analysis of the influence of radiation dose, fractionation schedules and surgical treatment techniques on cosmetic results. Radiother Oncol 1989;16:253-267.
15. Ullrich RL, Casarett GW. Interrelationship between the early inflammatory response and subsequent flbrosis after radiation exposure. Radiation Research 1977;72:107-121.
16. 3H]thymidine and gallium-67. J Nucl Med 1991;32:2118-2123.
17. Rege SD, Chaiken L, Hoh CK, et al. Change induced by radiation therapy in FDG uptake in normal and malignant structures of the head and neck: quantitation with PET. Radiology 1993;189:807-812.
18. Lowe VJ, Herbert ME, Hawk TC, Ansher MS, Coleman RE. Chest wall FDG accumulation in serial FDG-PET images in patients being treated for bronchogenic carcinoma with radiation [Abstract]. J Nucl Med 1994;35:76P.
19. Kubota K, Matsuzawa T, Takahasi T, et al. Rapid and sensitive response of carbon-11-L-methionine tumor uptake to irradiation. J Nucl Med 1989;30:2012-2016.
20. Kubota K, Kubota R, Matsuzawa T. Dose-responsive growth inhibition by glucocorticoid and its receptors in mouse teratocarcinoma OTT6050 in vivo. Cancer Res 1983;43:787-793.
21. 11C]methionine; feasibility for monitoring recurrence of tumor. Nucl Med Biol 1991;19:27-32.
22. Hall EJ. Time, dose and fractionation in radiotherapy. In: Hall EJ, ed. Radiobiology for the radiologist, 4th ed. Philadelphia, PA: Lippincott; 1994:211-229.
23. Lovett EJ, Alderman J, Munster E, Lundy J. Suppressive effects of thiopental and halothane on specific arms of the immune response. J Surg Oncol 1980;15:327-334.
24. 31P NMR spectroscopic and near infrared spectrophotometric studies of effects of anesthetics on in vivo RIF-1 tumors. NMR Biomed 1989;2:87-92.
25. Kimler BF, Liu C, Evans RG, Morantz RA. Effect of pentobarbital on normal brain protection and on the response of 9L rat brain tumor to radiation therapy. J Neurosurg 1993;79;577-583.
26. Patz EF, Lowe VJ, Hoffman JM, Paine SS, Harris LK, Goodman PC. Persistent or recurrent bronchogenic carcinoma: detection with PET and 2-[F-18]-2-deoxy-D-glucose. Radiology 1994;191:379-382.
27. Kairento AL, Brownell GL, Elmaleh DR, Swartz MR. Comparative measurement of regional blood flow, oxygen and glucose utilization in soft tissue tumor of rabbit with positron imaging. Br J Radiology 1985;58:637-643.
28. Cartee GD, Donan AG, Ramlal T, Klip A, Holloszy JO. Stimulation of glucose transport in skeletal muscle by hypoxia. J Appl Physiol 1991;70:1593-1600.
29. Bashan N, Burdett E, Hundel HS, Klip A. Regulation of glucose transportand GLUT 1 glucose transporter expression by 3% O2 in muscle cells in culture. Am J Physiol 1992;262:682-690.
30. Shetty M, Loeb JN, Ismail-Beigi F. Enhancement of glucose transport in response to inhibition of oxidative metabolism: pre- and posttranslational mechanisms. Am J Physiol 1992;262:527-532.
31. Bashan N, Burdett E, Guma A, Sargeant R, Tumiati L, Liu Z, Klip A. Mechanisms of adaptation of glucose transporters to changes in the oxidative chain of muscle and fat cells. Am J Physiol 1993;264:430-440.
32. 1 ATP-synthase of cardiac muscle during aging. Cardioscience 1993;4:93-98.
33. Lakatta EG, Yin FC. Myocardial aging: functional alterations and related cellular mechanisms. Am J Physiol 1982;242:H927-H941.
34. Kubota K, Kubota R, Yamada S. FDG accumulation in tumor tissue. J Nucl Med 1993;34:419-421.
35. Bustos R, Sobrino F. Stimulation of glycolysis as an activation signal in rat peritoneal macrophages. Biochem J 1992;282:299-303.
36. Kubota R, Kubota K, Yamada S, Tada M, Ido T, Tamahashi N. Active and passive mechanisms of [fluorine-18] fluorodeoxyglucose uptake by proliferating and prenecrotic cancer cells in vivo: a microautoradiographic study. J Nucl Med 1994;35:1067-1075.